logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Cempra Pharmaceuticals, Inc.

USPTO Granted Patents = 19

% Expired Patents = 73.7



Forward Citations = 76

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Prabhavathi Fernandes (11 out of 11 patents)

silverMedal David Eugene Pereira (11 out of 21 patents)

bronzeMedal Keshav Deo (2 out of 6 patents)

4.  Manish Kanchanbhai Patel (2 out of 2 patents)

5.  Sara Wu (1 out of 1 patent)

6.  Ronald Norman Jones (1 out of 1 patent)

7.  Prabhavathi B Fernandes (1 patent)

8.  Ronald Jones (0 patent)


19 patents:

1. 10188674 - Parenteral formulations for administering macrolide antibiotics (2019-01-29),
2. 10131684 - Process for the preparation of macrolide antibacterial agents (2018-11-20),
3. 9937194 - Compounds and methods for treating inflammatory diseases (2018-04-10),
4. 9901592 - Methods for treating resistant diseases using triazole containing macrolides (2018-02-27),
5. 9861616 - Methods for treating respiratory diseases and formulations therefor (2018-01-09),
6. 9815863 - Hydrogen bond forming fluoro ketolides for treating diseases (2017-11-14),
7. 9751908 - Convergent processes for preparing macrolide antibacterial agents (2017-09-05),
8. 9669046 - Biodefenses using triazole-containing macrolides (2017-06-06),
9. 9480679 - Methods for treating malaria, tuberculosis and MAC diseases (2016-11-01),
10. 9453042 - Process for the preparation of macrolide antibacterial agents (2016-09-27),
11. 9439918 - Methods for treating gastrointestinal diseases (2016-09-13),
12. 9072759 - Biodefenses using triazole-containing macrolides (2015-07-07),
13. 9051346 - Process for preparing triazole-containing ketolide antibiotics (2015-06-09),
14. 8975386 - Crystalline forms of a macrolide, and uses therefor (2015-03-10),
15. 8796232 - Methods for treating resistant diseases using triazole containing macrolides (2014-08-05),
Company Overview
Cempra Pharmaceuticals, Inc. is a biopharmaceutical company based in Chapel Hill, North Carolina, focused on developing innovative therapies for infectious diseases. The company specializes in the research and development of antibiotics to address unmet medical needs, particularly in the treatment of serious bacterial infections. Cempra's commitment to advancing healthcare solutions is reflected in its dedication to creating effective and safe treatments that can improve patient outcomes in the evolving landscape of infectious disease management.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#6 in Chapel Hill, NC

#381 in North Carolina

#17,150 in US

#32,693 in the World

Chapel Hill, NC (US)
Chapel Hill, NC, United States of America

Cempra Pharmaceuticals, Inc.

Forward Citations = 76

6 inventors:

goldMedal Prabhavathi Fernandes (11 out of 11 patents)

silverMedal David Eugene Pereira (11 out of 21 patents)

bronzeMedal Keshav Deo (2 out of 6 patents)

4.  Manish Kanchanbhai Patel (2 out of 2 patents)

5.  Sara Wu (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cempra Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/cempra-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…